Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Phio Pharmaceuticals Corp
(NQ:
PHIO
)
2.980
-0.170 (-5.40%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
34,061
Open
3.110
Bid (Size)
2.980 (5)
Ask (Size)
3.050 (5)
Prev. Close
3.150
Today's Range
2.910 - 3.220
52wk Range
2.400 - 18.81
Shares Outstanding
860,721
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
October 24, 2024
Marlborough, Massachusetts--(Newsfile Corp. - October 24, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical stage biotechnology company whose proprietary...
Via
Newsfile
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 21, 2024
Via
Benzinga
Performance
YTD
-56.98%
-56.98%
1 Month
-13.62%
-13.62%
3 Month
-6.88%
-6.88%
6 Month
-56.50%
-56.50%
1 Year
-73.30%
-73.30%
More News
Read More
Why Spirit Airlines Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
October 21, 2024
Via
Benzinga
Correction to Registration Link to Access Phio Pharmaceuticals' Presentation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
October 18, 2024
Via
Newsfile
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-deal Roadshow Series
October 18, 2024
Via
Newsfile
Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer Conference
October 16, 2024
Via
Newsfile
12 Health Care Stocks Moving In Thursday's After-Market Session
October 10, 2024
Via
Benzinga
Phio Announces Data Showcasing INTASYL's Role in Helping Immune Cells Target and Kill Cancer Cells
October 07, 2024
Via
Newsfile
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
October 02, 2024
Via
Newsfile
Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT's 2024 Advancing Gene + Cell Therapies for Cancer Conference
October 01, 2024
Via
Newsfile
INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society
September 25, 2024
Via
Newsfile
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
September 17, 2024
Via
Newsfile
Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA
September 16, 2024
Via
Newsfile
Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 09, 2024
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
August 29, 2024
Via
Newsfile
PHIO Stock Earnings: Phio Pharma Misses EPS for Q2 2024
August 14, 2024
Via
InvestorPlace
Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
August 14, 2024
Via
Newsfile
Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phio's Patented INTASYL Compound
August 06, 2024
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
Phio Pharmaceuticals Announces New Chief Financial Officer
August 01, 2024
Via
Newsfile
Topics
Initial Public Offering
Exposures
Securities Market
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 29, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
July 29, 2024
Via
InvestorPlace
Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
July 29, 2024
Via
Benzinga
Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds
July 12, 2024
Via
Newsfile
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762
July 08, 2024
Via
Newsfile
Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds
July 05, 2024
Via
Newsfile
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.